These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 3056557)

  • 1. Demonstration of chimerism after bone marrow transplantation by reticulocyte blood group typing.
    Zuazu J; Duran-Suarez JR; Julia A; Martin Vega C; Massague I; Massuet L
    Bone Marrow Transplant; 1988 Sep; 3(5):521-2. PubMed ID: 3056557
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemolysis in Rh-negative female recipient after Rh-incompatible bone marrow transplantation for chronic myeloid leukemia.
    Girelli G; Arcese W; Bianchi A; Mauro FR; Malagnino F; Adorno G; Iurlo A; Perrone MP; Papa G
    Haematologica; 1986; 71(1):46-9. PubMed ID: 3084356
    [No Abstract]   [Full Text] [Related]  

  • 3. [Progress in confirmation of bone marrow engraftment and analysis of hematopoietic chimerism].
    Yabe H
    Nihon Rinsho; 1990 Sep; 48(9):1983-8. PubMed ID: 1977942
    [No Abstract]   [Full Text] [Related]  

  • 4. Sequential molecular monitoring of chimerism in chronic myeloid leukemia patients receiving donor lymphocyte transfusion for relapse after bone marrow transplantation.
    Rapanotti MC; Arcese W; Buffolino S; Iori AP; Mengarelli A; De Cuia MR; Cardillo A; Cimino G
    Bone Marrow Transplant; 1997 Apr; 19(7):703-7. PubMed ID: 9156248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of indirect immunofluorescence in blood group serology].
    Wagner F
    Beitr Infusionsther Transfusionsmed; 1994; 32():169-70. PubMed ID: 9480078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
    Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
    Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed monitoring of hematopoietic chimerism in a child treated by adoptive immunotherapy for high risk of relapse after BMT for acute myeloid leukemia.
    Formánková R; Honzátková L; Sieglová Z; Starý J; Sedlácek P; Brdicka R
    Bone Marrow Transplant; 2000 Feb; 25(4):453-6. PubMed ID: 10723591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Method dependency of blood group determination after bone marrow transplantation.
    Wagner F; Wölpl A; Greher J; Kubanek B
    Beitr Infusionsther Transfusionsmed; 1994; 32():171-4. PubMed ID: 9422110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the time course of mixed chimerism by fluorescent in situ hybridization in patients with chronic myeloid leukemia after allogenic transplantation of bone marrow].
    Vinogradova OA; Savchenko VG; Neverova AL; Diachenko LV; Domracheva EV; Liubimova LS; Mendeleeva LP
    Ter Arkh; 2001; 73(7):26-34. PubMed ID: 11523405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study.
    Choi SJ; Lee KH; Lee JH; Kim S; Chung HJ; Lee JS; Kim SH; Park CJ; Chi HS; Kim WK
    Bone Marrow Transplant; 2000 Aug; 26(3):327-32. PubMed ID: 10967574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats.
    Frankel W; Chan A; Corringham RE; Shepherd S; Rearden A; Wang-Rodriguez J
    Am J Hematol; 1996 Aug; 52(4):281-7. PubMed ID: 8701946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunocytologic identification of blood group substances in blood and bone marrow smears--its usefulness in bone marrow transplantation and leukemia].
    Manabe S; Yamada M; Mori S; Kodo H; Asano S; Miwa S
    Rinsho Byori; 1985 Oct; 33(10):1124-8. PubMed ID: 3910861
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of microsatellite markers for monitoring of reconstitution pattern in patients after bone marrow transplantation/peripheral blood progenitor cell transplantation.
    Jungerman M; Sedzimirska M; Lange A; Witt M
    Arch Immunol Ther Exp (Warsz); 1998; 46(1):39-43. PubMed ID: 9510945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chimerism of cardiomyocytes and endothelial cells after allogeneic bone marrow transplantation in chronic myeloid leukemia. An autopsy study].
    Thiele J; Varus E; Wickenhauser C; Kvasnicka HM; Metz K; Schaefer UW; Beelen DW
    Pathologe; 2002 Nov; 23(6):405-10. PubMed ID: 12436292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
    Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte antigen and reticulocyte engraftment after allogeneic hematopoietic stem cell transplantation.
    Yildirim I; Ozer Y; Yüksel MK; Arat M; Arslan O
    Bone Marrow Transplant; 2004 Aug; 34(4):351-5. PubMed ID: 15170158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular cytogenetic monitoring of chimerism and minimal residual disease in patient with chronic myeloid leukemia after allogenic and syngenic bone marrow transplantation].
    Vinogradova OA; Savchenko VG; Domracheva EV; Liubimova LS; Ol'shanskaia IuV; Diachenko LV; Parovichnikova EN; Mendeleeva LP; Zakharova AV
    Ter Arkh; 2002; 74(7):38-44. PubMed ID: 12181833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.